title: Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector (GENEGRAFT).
mesh_terms: D002986:Clinical Trials as Topic; D024143:Collagen Type VII / Q000235:genetics* / Q000378:metabolism; D016108:Epidermolysis Bullosa Dystrophica / Q000628:therapy*; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism / Q000637:transplantation; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D015603:Keratinocytes / Q000166:cytology / Q000378:metabolism / Q000637:transplantation; D012190:Retroviridae / Q000235:genetics*
chemical_list: D024143:Collagen Type VII